Endometrial carcinoma. Is routine intensive periodic follow-up of value?

European Journal of Gynaecological Oncology

Volumn 21, Issue 5, 2000, Pages 461-465

  Menczer, J ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RECURRENCE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; REVIEW; TREATMENT PLANNING;

ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; VAGINAL NEOPLASMS;

EID: 0034510881     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Surveillance for recurrent endometrial carcinoma: Development of a follow-up scheme
2. Clinical surveillance of gynecologic oncology patients
3. Post surgical surveillance of patients with stage I/II endometrial adenocarcinoma
4. Use of serum CA125 measurement in post-treatment surveillance of early stage endometrial carcinoma
5. Detection and patterns of treatment failure in 300 consecutive cases of 'early' endometrial cancer after primary surgery
6. Treatment failure in endometrial carcinoma
7. Recurrent adenocarcinoma of the endometrium: A clinical histopathological study of 379 patients
8. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
9. Risk factors and recurrent patterns in stage I endometrial cancer
10. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium
11. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma
12. Risk-specific follow-up for endometrial carcinoma patients
13. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study
14. Low-risk endometrial carcinoma: Assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators
15. DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma
16. Her/2 neu, p53, and DNA analysis as prognosticators for survival in endometrial carcinoma
17. Clinical value of new techniques of gynecological tumor assessment
18. Prognostic significance of tumor angiogenesis in endometrial cancer
19. Isolated vaginal recurrences of endometrial carcinoma
20. Isolated vaginal recurrences in endometrial carcinoma: Treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy
21. Prognostic factors and treatment outcome in patients with locally recurrent endometrial cancer
22. Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial carcinoma
23. Treatment of recurrent adenocarcinoma of the endometrium with exenteration
24. Treatment of advanced or recurrent endometrial carcinoma with single agent carboplatin
25. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group study
26. Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxy-progesteron acetate in the treatment of endometrial carcinoma
27. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
28. Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: A phase II study
29. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
30. Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future directions
31. Long term follow-up of gonadotrophin-releasing hormone treatment for recurrent endometrial cancer
32. An evaluation of routine follow-up of patients treated for endometrial carcinoma
33. Is there any value in the long term follow up of women treated for endometrial cancer?
34. Recurrence of endometrial carcinoma and the value of routine follow-up
35. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma
36. The value of intensive follow-up after curative resection for colorectal carcinoma
37. Colonoscopic surveillance after curative resection for colorectal cancer
38. Standard postoperative monitoring of patients after primary resection of colon and rectum cancer
39. Impact of follow-up testing on servival and health-related quality of life in breast cancer patients: A multicenter randomized control study
40. Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial